US Patent Issued to Theripion on Dec. 30 for "Polynucleotides encoding APOA-1 fusion polypeptides" (Washington Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,501, issued on Dec. 30, was assigned to Theripion Inc. (Shoreline, Wash.).

"Polynucleotides encoding APOA-1 fusion polypeptides" was invented by Martha S. Hayden-Ledbetter (Shoreline, Wash.) and Jeffrey A. Ledbetter (Shoreline, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods relating to ApoA-1 fusion polypeptides are disclosed. The fusion polypeptides include a first polypeptide segment corresponding to an ApoA-1 polypeptide or ApoA-1 mimetic, and may also include a dimerizing domain such as, e.g., an Fc region, which is typically linked carboxyl-terminal to the first polypeptide segment via a flexible linker. In some e...